|
RENEW Intervention for Axial Spondyloarthritis
RECRUITINGN/ASponsored by University of Michigan
Actively Recruiting
PhaseN/A
SponsorUniversity of Michigan
Started2026-10-22
Est. completion2027-03
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07836374
Summary
The researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have axial spondyloarthritis (axSpA). There are 3 main reasons the researchers are doing this study: 1) to test how easy it is for people with spondyloarthritis to use the RENEW program; 2) to assess whether people like the RENEW program and 3) to understand if it helps with symptom management and disease burden.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Physician-diagnosed axSpA (including non-radiographic axSpA) * Have moderate to severe fatigue (average of ≥4/7 on the Fatigue Severity Scale) * Access to a computer, tablet, or smartphone with internet connection * Ability to speak and read English * Willingness to participate in virtual Zoom coaching sessions and complete online assessments * Interested in making some changes and trying new ways to improve health and well-being Exclusion Criteria: * Currently enrolled in other clinical trials * Currently undergoing structured rehabilitation or psychological treatment for major depressive disorder * Significant cognitive impairment that would prevent informed consent or participation * Severe psychiatric illness that would contraindicate participation
Conditions2
ArthritisAxial Spondyloarthritis
Locations1 site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Michigan
Started2026-10-22
Est. completion2027-03
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07836374